Navigation Links
Cepheid to Webcast Upcoming Financial Presentations
Date:2/1/2012

SUNNYVALE, Calif., Feb. 1, 2012 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast.

Leerink Swann Global Healthcare Conference, New York, NY
Wednesday, February 15, 2012 at 11.30 a.m. Eastern Time

Raymond James Annual Conference, Orlando, FL
Tuesday, March 6, 2012 at 1.05 p.m. Eastern Time

Additionally, Cepheid announced that it will participate in The NASDAQ Opening Bell ceremony at The NASDAQ Stock Market on Tuesday, February 7, 2012. The ceremony commemorates the continued growth and innovation of Cepheid's GeneXpert® system which saw record placements in 2011, and will take place at 9:30 a.m. Eastern Time at The NASDAQ MarketSite Studio in Times Square, New York City.

Accessing Live Webcasts To access the live webcasts for the two investor conferences, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcasts will be available shortly following the presentation and will remain available for at least 90 days.

About CepheidBased in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to access the full power of molecular diagnostics. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www.cepheid.com

CONTACTS:

 

  For Media Inquiries: For Investor Inquiries:  

Jared Tipton

Cepheid Corporate Communications

Tel: (408) 400-8377

communications@cepheid.com

Jacquie Ross

Cepheid Investor Relations

Tel: (408) 400-8329

investor.relations@cepheid.com

 

 


'/>"/>

SOURCE Cepheid
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Cepheid Reports Fourth Quarter and Full Year 2011 Results
2. Cepheid Welcomes Senior Vice President of Human Resources
3. Cepheid Receives FDA Clearance for Xpert Flu, Delivering Simultaneous Detection and Differentiation of Flu A, Flu B, and 2009 H1N1 Strain
4. Cepheid Schedules 2010 Third Quarter Financial Results Announcement and Webcast
5. Cepheid to Webcast Upcoming Financial Presentations
6. Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations
7. Cepheid Schedules 2009 Third Quarter Financial Results Announcement and Webcast
8. Cepheid Schedules 2009 Second Quarter Financial Results Announcement and Webcast
9. Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
10. Cepheid Reports 2009 First Quarter Results
11. Cepheid Schedules Fiscal 2009 First Quarter Financial Results Announcement and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... June 27, 2017 , ... DuPont Pioneer (DuPont) and ERS ... the ERS patent portfolio covering CRISPR-Cas genome editing technology for all agricultural uses ... (IP) of the CRISPR-Cas technology from co-inventor and co-owner Emmanuelle Charpentier, Ph.D. ...
(Date:6/23/2017)... ... June 23, 2017 , ... Biova, LLC., the leader in water ... Board of Directors. Dr. Henig will bring a wealth of scientific experience in the ... the Chief Technical and Scientific Officer of four major global companies in the last ...
(Date:6/22/2017)... ... 21, 2017 , ... Beaker, the industry’s pioneer in developing ... sciences industry, today announces a strategic partnership with Alcami Corporation, a leading global ... Beaker’s expertise in executive recruitment solutions, providing Alcami with access to the best ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... RegMedNet has produced a Spotlight series on “Cell Therapy Regulation” ... perspectives by leading experts on the unique regulatory challenges of stem cell medical ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... 2017 Trends, opportunities and forecast in this ... technology (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, ... end use industry (government and law enforcement, commercial and ... and others), and by region ( North America ... Asia Pacific , and the Rest of the ...
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
Breaking Biology News(10 mins):